Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rossella Fioravanti

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Drug Discovery Today|November 12, 2022
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?Clemens Zwergel, Rossella Fioravanti, Antonello Mai
Expert Opinion on Therapeutic Patents|June 18, 2010
Focusing on new monoamine oxidase inhibitorsAdriana Bolasco, Simone Carradori, Rossella Fioravanti
Chimia|December 9, 2023
Current HDAC Inhibitors in Clinical TrialsElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Frontiers in Pharmacology|February 23, 2023
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trialsBeatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Current Opinion in Chemical Biology|April 16, 2019
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancerGiulia Stazi, Rossella Fioravanti, Antonello Mai, et al.
Biotechnology and Applied Biochemistry|May 18, 2010
Use of cyclodextrins in biotransformation reactions with cell cultures of Morus nigra: biosynthesis of prenylated chalcone isocordoinAdriana Bolasco, Rossella Fioravanti, Francesca Rossi, et al.
Current Opinion in Structural Biology|August 5, 2023
Histone deacetylase 10: A polyamine deacetylase from the crystal structure to the first inhibitorsChiara Lambona, Clemens Zwergel, Rossella Fioravanti, et al.
Chemical Record (New York, N.Y.)|October 20, 2018
Six Years (2012-2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2-Pyridone CompoundsRossella Fioravanti, Giulia Stazi, Clemens Zwergel, et al.
Journal of Chromatography. A|December 10, 2013
A chromatographic and computational study on the driving force operating in the exceptionally large enantioseparation of N-thiocarbamoyl-3-(4'-biphenyl)-5-phenyl-4,5-dihydro-(1H) pyrazole on a 4-methylbenzoate cellulose-based chiral stationary phaseFrancesco Ortuso, Stefano Alcaro, Sergio Menta, et al.
Current Opinion in Chemical Biology|July 3, 2020
Targeting histone acetylation/deacetylation in parasites: an update (2017-2020)Rossella Fioravanti, Nicola Mautone, Annarita Rovere, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Drug Discovery Today|November 12, 2022
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?Clemens Zwergel, Rossella Fioravanti, Antonello Mai
Expert Opinion on Therapeutic Patents|June 18, 2010
Focusing on new monoamine oxidase inhibitorsAdriana Bolasco, Simone Carradori, Rossella Fioravanti
Chimia|December 9, 2023
Current HDAC Inhibitors in Clinical TrialsElisabetta Di Bello, Beatrice Noce, Rossella Fioravanti, et al.
Frontiers in Pharmacology|February 23, 2023
LSD1 inhibitors for cancer treatment: Focus on multi-target agents and compounds in clinical trialsBeatrice Noce, Elisabetta Di Bello, Rossella Fioravanti, et al.
Current Opinion in Chemical Biology|April 16, 2019
Histone deacetylases as an epigenetic pillar for the development of hybrid inhibitors in cancerGiulia Stazi, Rossella Fioravanti, Antonello Mai, et al.
Biotechnology and Applied Biochemistry|May 18, 2010
Use of cyclodextrins in biotransformation reactions with cell cultures of Morus nigra: biosynthesis of prenylated chalcone isocordoinAdriana Bolasco, Rossella Fioravanti, Francesca Rossi, et al.
Current Opinion in Structural Biology|August 5, 2023
Histone deacetylase 10: A polyamine deacetylase from the crystal structure to the first inhibitorsChiara Lambona, Clemens Zwergel, Rossella Fioravanti, et al.
Chemical Record (New York, N.Y.)|October 20, 2018
Six Years (2012-2018) of Researches on Catalytic EZH2 Inhibitors: The Boom of the 2-Pyridone CompoundsRossella Fioravanti, Giulia Stazi, Clemens Zwergel, et al.
Journal of Chromatography. A|December 10, 2013
A chromatographic and computational study on the driving force operating in the exceptionally large enantioseparation of N-thiocarbamoyl-3-(4'-biphenyl)-5-phenyl-4,5-dihydro-(1H) pyrazole on a 4-methylbenzoate cellulose-based chiral stationary phaseFrancesco Ortuso, Stefano Alcaro, Sergio Menta, et al.
Current Opinion in Chemical Biology|July 3, 2020
Targeting histone acetylation/deacetylation in parasites: an update (2017-2020)Rossella Fioravanti, Nicola Mautone, Annarita Rovere, et al.
Pageof 7